Protective Effect of Peroxisome Proliferator Activated Receptor Gamma Agonists on Diabetic and Non‐diabetic Renal Diseases

BH Chung,SW Lim,KO Ahn,A Sugawara,S Ito,BS Choi,YS Kim,BK Bang,CW Yang
DOI: https://doi.org/10.1111/j.1440-1797.2005.00456.x
2005-01-01
Nephrology
Abstract:Peroxisome proliferator activated receptor gamma (PPARgamma) agonist has not only antidiabetic effect but also a protective effect against various types of injury of the kidney. The protective effects of PPARgamma agonists are observed in diabetic nephropathy and non-diabetic renal diseases such as 5/6 ablation model of renal failure, experimental glomerulonephritis, ischemia-reperfusion injury, hypertensive nephropathy and cyclosporin-induced renal injury. The mechanism of renoprotection by PPARgamma agonist is multifactorial. Anti-fibrotic and anti-inflammatory effects, suppression of renin-angiotensin system, vascular protective effect and antiapoptotic effect were proposed.
What problem does this paper attempt to address?